Similarly, another study focused on hypoxia-regulated ferroptosis in HCC cells and pinpointed the HIF-1α/METTL14/YTHDF2/SLC7A11 axis as a potential therapeutic target for HCC interventional embolization treatment 70. This evidence concerns the gene YTHDF2 and hepatocellular carcinoma.